Lumida
/CAMP
⌘K
CAMP4 Therapeutics Corp

CAMP4 Therapeutics Corp

CAMP
$4.25USD-2.07%-0.09 today

MARKET CAP

266.7M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $5

52W RANGE

$2
$8
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$308.6M$295.8M$294.9M$652,000$3.5M
YoY %-4.1%-4.1%-0.3%-99.8%+436.5%
P / Sales30.3x19.4x12.0x37.5x53.2x
EV / Sales31.1x20.2x13.1x-37.4x42.0x
Gross Profit, Adj.$122.4M$121.9M$109.0M$652,000$3.5M
YoY %-2.5%-0.4%-10.6%-99.4%+436.5%
Margin %39.7%41.2%37.0%100.0%100.0%
EV / Gross Profit78.4x48.9x35.5x-37.4x42.0x
EBITDA, Adj.$18.5M$9.9M$1.7M$-51.4M$-50.4M
YoY %-2.9%-46.4%-83.3%-3197.8%+1.9%
Margin %6.0%3.4%0.6%-7882.2%-1441.5%
EV / EBITDA517.5x600.1x2334.2x0.5x-2.9x
EBIT$-6.8M$-13.5M$-24.7M$-53.1M$-52.6M
YoY %+45.2%-97.4%-83.3%-115.1%+1.0%
Margin %-2.2%-4.6%-8.4%-8142.3%-1502.4%
EV / EBIT-1405.6x-442.6x-156.9x0.5x-2.8x
Net Income$-56.3M$-28.0M$-32.5M$-51.8M$-80.4M
YoY %+29.0%+50.3%-16.1%-59.4%-55.2%
Net Margin-18.2%-9.5%-11.0%-7943.4%-2298.5%
EPS (GAAP)-$1.64-$0.79-$0.90-$11.04-$2.65
YoY %+30.5%+51.8%-13.9%-1126.7%+76.0%